vs

Side-by-side financial comparison of electroCore, Inc. (ECOR) and Linde plc (LIN). Click either name above to swap in a different company.

electroCore, Inc. is the larger business by last-quarter revenue ($9.2M vs $8.8M, roughly 1.1× Linde plc). On growth, electroCore, Inc. posted the faster year-over-year revenue change (31.2% vs 8.2%). Over the past eight quarters, electroCore, Inc.'s revenue compounded faster (30.3% CAGR vs -96.7%).

electroCore, Inc. is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation.

Linde is a global multinational chemical company and the world's largest industrial gas supplier by market share and revenue. Founded by German scientist and engineer Carl von Linde in 1879 in Wiesbaden, Germany, the company is now headquartered in Woking, United Kingdom, and registered in Ireland as Linde plc. Linde plc was formed in 2018 through the merger of Linde AG and Praxair, which was founded in 1907 in the United States as Linde Air Products Company.

ECOR vs LIN — Head-to-Head

Bigger by revenue
ECOR
ECOR
1.1× larger
ECOR
$9.2M
$8.8M
LIN
Growing faster (revenue YoY)
ECOR
ECOR
+22.9% gap
ECOR
31.2%
8.2%
LIN
Faster 2-yr revenue CAGR
ECOR
ECOR
Annualised
ECOR
30.3%
-96.7%
LIN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ECOR
ECOR
LIN
LIN
Revenue
$9.2M
$8.8M
Net Profit
$-3.0M
Gross Margin
88.4%
48.5%
Operating Margin
-31.8%
27.8%
Net Margin
-32.8%
Revenue YoY
31.2%
8.2%
Net Profit YoY
6.0%
EPS (diluted)
$-0.34
$3.98

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECOR
ECOR
LIN
LIN
Q1 26
$8.8M
Q4 25
$9.2M
$8.8B
Q3 25
$8.7M
$8.6B
Q2 25
$7.4M
$8.5B
Q1 25
$6.7M
$8.1B
Q4 24
$7.0M
$8.3B
Q3 24
$6.6M
$8.4B
Q2 24
$6.1M
$8.3B
Net Profit
ECOR
ECOR
LIN
LIN
Q1 26
Q4 25
$-3.0M
$1.5B
Q3 25
$-3.4M
$1.9B
Q2 25
$-3.7M
$1.8B
Q1 25
$-3.9M
$1.7B
Q4 24
$-3.2M
$1.7B
Q3 24
$-2.5M
$1.6B
Q2 24
$-2.7M
$1.7B
Gross Margin
ECOR
ECOR
LIN
LIN
Q1 26
48.5%
Q4 25
88.4%
Q3 25
86.0%
Q2 25
87.3%
Q1 25
84.9%
Q4 24
85.9%
Q3 24
83.8%
Q2 24
86.3%
Operating Margin
ECOR
ECOR
LIN
LIN
Q1 26
27.8%
Q4 25
-31.8%
23.0%
Q3 25
-33.2%
27.5%
Q2 25
-47.5%
27.7%
Q1 25
-56.9%
26.9%
Q4 24
-43.6%
27.4%
Q3 24
-40.4%
25.0%
Q2 24
-42.2%
26.4%
Net Margin
ECOR
ECOR
LIN
LIN
Q1 26
Q4 25
-32.8%
17.5%
Q3 25
-39.2%
22.4%
Q2 25
-49.7%
20.8%
Q1 25
-57.4%
20.6%
Q4 24
-45.8%
20.8%
Q3 24
-38.1%
18.5%
Q2 24
-43.2%
20.1%
EPS (diluted)
ECOR
ECOR
LIN
LIN
Q1 26
$3.98
Q4 25
$-0.34
$3.28
Q3 25
$-0.40
$4.09
Q2 25
$-0.44
$3.73
Q1 25
$-0.47
$3.51
Q4 24
$-0.37
$3.61
Q3 24
$-0.31
$3.22
Q2 24
$-0.38
$3.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECOR
ECOR
LIN
LIN
Cash + ST InvestmentsLiquidity on hand
$11.6M
$4.0M
Total DebtLower is stronger
$7.8M
$24.7M
Stockholders' EquityBook value
$-1.7M
$40.1M
Total Assets
$18.7M
$86.3M
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECOR
ECOR
LIN
LIN
Q1 26
$4.0M
Q4 25
$11.6M
$5.1B
Q3 25
$13.0M
$4.5B
Q2 25
$7.1M
$4.8B
Q1 25
$7.8M
$5.3B
Q4 24
$12.2M
$4.8B
Q3 24
$12.9M
$5.2B
Q2 24
$14.2M
$4.6B
Total Debt
ECOR
ECOR
LIN
LIN
Q1 26
$24.7M
Q4 25
$7.8M
$20.7B
Q3 25
$7.8M
$18.6B
Q2 25
$19.7B
Q1 25
$17.6B
Q4 24
$15.3B
Q3 24
$17.5B
Q2 24
$16.9B
Stockholders' Equity
ECOR
ECOR
LIN
LIN
Q1 26
$40.1M
Q4 25
$-1.7M
$38.2B
Q3 25
$-1.1M
$38.6B
Q2 25
$1.1M
$38.5B
Q1 25
$4.4M
$38.0B
Q4 24
$7.5M
$38.1B
Q3 24
$9.5M
$39.2B
Q2 24
$11.5M
$38.2B
Total Assets
ECOR
ECOR
LIN
LIN
Q1 26
$86.3M
Q4 25
$18.7M
$86.8B
Q3 25
$21.4M
$86.0B
Q2 25
$14.6M
$86.1B
Q1 25
$16.0M
$82.7B
Q4 24
$20.5M
$80.1B
Q3 24
$21.0M
$82.5B
Q2 24
$22.4M
$80.2B
Debt / Equity
ECOR
ECOR
LIN
LIN
Q1 26
0.62×
Q4 25
0.54×
Q3 25
0.48×
Q2 25
0.51×
Q1 25
0.46×
Q4 24
0.40×
Q3 24
0.45×
Q2 24
0.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECOR
ECOR
LIN
LIN
Operating Cash FlowLast quarter
$-1.5M
Free Cash FlowOCF − Capex
$898.0K
FCF MarginFCF / Revenue
10.2%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$4.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECOR
ECOR
LIN
LIN
Q1 26
Q4 25
$-1.5M
$3.0B
Q3 25
$-1.7M
$2.9B
Q2 25
$-623.0K
$2.2B
Q1 25
$-4.4M
$2.2B
Q4 24
$-1.3M
$2.8B
Q3 24
$-1.4M
$2.7B
Q2 24
$-1.8M
$1.9B
Free Cash Flow
ECOR
ECOR
LIN
LIN
Q1 26
$898.0K
Q4 25
$1.6B
Q3 25
$-1.7M
$1.7B
Q2 25
$-648.0K
$954.0M
Q1 25
$-4.4M
$891.0M
Q4 24
$1.6B
Q3 24
$1.7B
Q2 24
$796.0M
FCF Margin
ECOR
ECOR
LIN
LIN
Q1 26
10.2%
Q4 25
17.9%
Q3 25
-19.3%
19.4%
Q2 25
-8.8%
11.2%
Q1 25
-65.4%
11.0%
Q4 24
18.8%
Q3 24
19.9%
Q2 24
9.6%
Capex Intensity
ECOR
ECOR
LIN
LIN
Q1 26
Q4 25
0.0%
16.6%
Q3 25
0.0%
14.8%
Q2 25
0.3%
14.8%
Q1 25
0.6%
15.7%
Q4 24
15.1%
Q3 24
12.8%
Q2 24
13.7%
Cash Conversion
ECOR
ECOR
LIN
LIN
Q1 26
Q4 25
1.98×
Q3 25
1.53×
Q2 25
1.25×
Q1 25
1.29×
Q4 24
1.63×
Q3 24
1.76×
Q2 24
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons